Bruker Corporation (NASDAQ: BRKR) Stock Competitors & Peer Comparison
See BRKR's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BRKR and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BRKR | $59.92 | +2.17% | 9.1B | 30.11 | $1.99 | +0.33% |
| ABT | $114.14 | -0.25% | 197.7B | 21.93 | $5.21 | +2.16% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $327.70 | -3.61% | 125.6B | 24.48 | $13.39 | +1.05% |
| MDT | $92.30 | -1.94% | 118.2B | 16.70 | $5.53 | +3.08% |
| BSX | $49.37 | -5.08% | 73.4B | 15.93 | $3.10 | N/A |
| EW | $89.83 | -2.65% | 51.7B | 33.26 | $2.70 | N/A |
| DXCM | $90.22 | +0.38% | 34B | 38.72 | $2.33 | N/A |
| RMD | $228.44 | -0.67% | 33.1B | 21.22 | $10.77 | +1.07% |
| PHG | $27.50 | +1.48% | 27B | 15.78 | $1.75 | +3.59% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
BRKR vs ABT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ABT has a market cap of 197.7B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ABT trades at $114.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ABT's P/E ratio is 21.93. In terms of profitability, BRKR's ROE is -0.03%, compared to ABT's ROE of +0.11%. Regarding short-term risk, BRKR is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
BRKR vs BSX-PA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, BRKR's ROE is -0.03%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, BRKR is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
BRKR vs SYK Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SYK has a market cap of 125.6B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SYK trades at $327.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SYK's P/E ratio is 24.48. In terms of profitability, BRKR's ROE is -0.03%, compared to SYK's ROE of +0.16%. Regarding short-term risk, BRKR is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SYK's competition here
Medtronic plc (NYSE: MDT)
BRKR vs MDT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, MDT has a market cap of 118.2B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while MDT trades at $92.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas MDT's P/E ratio is 16.70. In terms of profitability, BRKR's ROE is -0.03%, compared to MDT's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
BRKR vs BSX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BSX has a market cap of 73.4B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BSX trades at $49.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BSX's P/E ratio is 15.93. In terms of profitability, BRKR's ROE is -0.03%, compared to BSX's ROE of +0.15%. Regarding short-term risk, BRKR is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
BRKR vs EW Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while EW trades at $89.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas EW's P/E ratio is 33.26. In terms of profitability, BRKR's ROE is -0.03%, compared to EW's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
BRKR vs DXCM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, DXCM has a market cap of 34B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while DXCM trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas DXCM's P/E ratio is 38.72. In terms of profitability, BRKR's ROE is -0.03%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, BRKR is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
BRKR vs RMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, RMD has a market cap of 33.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while RMD trades at $228.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas RMD's P/E ratio is 21.22. In terms of profitability, BRKR's ROE is -0.03%, compared to RMD's ROE of +0.24%. Regarding short-term risk, BRKR is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
BRKR vs PHG Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, PHG has a market cap of 27B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while PHG trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas PHG's P/E ratio is 15.78. In terms of profitability, BRKR's ROE is -0.03%, compared to PHG's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
BRKR vs ZBH Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ZBH has a market cap of 19.2B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ZBH trades at $98.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ZBH's P/E ratio is 11.68. In terms of profitability, BRKR's ROE is -0.03%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
BRKR vs ABMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ABMD's P/E ratio is 65.36. In terms of profitability, BRKR's ROE is -0.03%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
BRKR vs PEN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, PEN has a market cap of 12.8B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while PEN trades at $323.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas PEN's P/E ratio is 84.57. In terms of profitability, BRKR's ROE is -0.03%, compared to PEN's ROE of +0.11%. Regarding short-term risk, BRKR is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
BRKR vs SWAV Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SWAV's P/E ratio is 78.76. In terms of profitability, BRKR's ROE is -0.03%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, BRKR is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
BRKR vs SNN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SNN has a market cap of 12.2B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SNN trades at $29.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SNN's P/E ratio is 13.66. In terms of profitability, BRKR's ROE is -0.03%, compared to SNN's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SNN's competition here
Globus Medical, Inc. (NYSE: GMED)
BRKR vs GMED Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, GMED has a market cap of 11.6B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while GMED trades at $85.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas GMED's P/E ratio is 19.30. In terms of profitability, BRKR's ROE is -0.03%, compared to GMED's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check GMED's competition here
Align Technology, Inc. (NASDAQ: ALGN)
BRKR vs ALGN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ALGN has a market cap of 11.4B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ALGN trades at $158.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ALGN's P/E ratio is 14.49. In terms of profitability, BRKR's ROE is -0.03%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ALGN's competition here
Glaukos Corporation (NYSE: GKOS)
BRKR vs GKOS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, GKOS has a market cap of 10.9B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while GKOS trades at $184.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas GKOS's P/E ratio is -214.73. In terms of profitability, BRKR's ROE is -0.03%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, BRKR is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
BRKR vs PODD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, PODD has a market cap of 10.5B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while PODD trades at $146.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas PODD's P/E ratio is 25.81. In terms of profitability, BRKR's ROE is -0.03%, compared to PODD's ROE of +0.27%. Regarding short-term risk, BRKR is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
BRKR vs BIO Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BIO has a market cap of 10.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BIO trades at $376.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BIO's P/E ratio is 40.57. In terms of profitability, BRKR's ROE is -0.03%, compared to BIO's ROE of +0.03%. Regarding short-term risk, BRKR is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
BRKR vs BIO-B Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BIO-B has a market cap of 10B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BIO-B trades at $365.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BIO-B's P/E ratio is -64.28. In terms of profitability, BRKR's ROE is -0.03%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, BRKR is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BIO-B's competition here
Masimo Corporation (NASDAQ: MASI)
BRKR vs MASI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas MASI's P/E ratio is 44.43. In terms of profitability, BRKR's ROE is -0.03%, compared to MASI's ROE of +0.09%. Regarding short-term risk, BRKR is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check MASI's competition here
Haemonetics Corporation (NYSE: HAE)
BRKR vs HAE Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, HAE has a market cap of 4.9B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while HAE trades at $108.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas HAE's P/E ratio is 21.59. In terms of profitability, BRKR's ROE is -0.03%, compared to HAE's ROE of +0.11%. Regarding short-term risk, BRKR is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
BRKR vs NARI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas NARI's P/E ratio is -59.24. In terms of profitability, BRKR's ROE is -0.03%, compared to NARI's ROE of -0.00%. Regarding short-term risk, BRKR is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
BRKR vs LIVN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while LIVN trades at $78.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas LIVN's P/E ratio is 18.58. In terms of profitability, BRKR's ROE is -0.03%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, BRKR is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
BRKR vs ITGR Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ITGR trades at $125.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ITGR's P/E ratio is 19.72. In terms of profitability, BRKR's ROE is -0.03%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, BRKR is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
BRKR vs IRTC Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while IRTC trades at $127.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas IRTC's P/E ratio is -199.97. In terms of profitability, BRKR's ROE is -0.03%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, BRKR is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
BRKR vs AXNX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas AXNX's P/E ratio is -709.80. In terms of profitability, BRKR's ROE is -0.03%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
BRKR vs TMDX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while TMDX trades at $90.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas TMDX's P/E ratio is 46.12. In terms of profitability, BRKR's ROE is -0.03%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, BRKR is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
BRKR vs AXGN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while AXGN trades at $46.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas AXGN's P/E ratio is 122.21. In terms of profitability, BRKR's ROE is -0.03%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, BRKR is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check AXGN's competition here
Butterfly Network, Inc. (NYSE: BFLY)
BRKR vs BFLY Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BFLY trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BFLY's P/E ratio is -38.19. In terms of profitability, BRKR's ROE is -0.03%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, BRKR is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BFLY's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
BRKR vs UFPT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while UFPT trades at $304.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas UFPT's P/E ratio is 31.08. In terms of profitability, BRKR's ROE is -0.03%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, BRKR is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check UFPT's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
BRKR vs ESTA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ESTA has a market cap of 2.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ESTA trades at $71.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ESTA's P/E ratio is -56.76. In terms of profitability, BRKR's ROE is -0.03%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, BRKR is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
BRKR vs NUVA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas NUVA's P/E ratio is 75.00. In terms of profitability, BRKR's ROE is -0.03%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, BRKR is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
BRKR vs NVCR Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, NVCR has a market cap of 2.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while NVCR trades at $17.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas NVCR's P/E ratio is -11.61. In terms of profitability, BRKR's ROE is -0.03%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, BRKR is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
BRKR vs INSP Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while INSP trades at $61.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas INSP's P/E ratio is 26.96. In terms of profitability, BRKR's ROE is -0.03%, compared to INSP's ROE of +0.18%. Regarding short-term risk, BRKR is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
BRKR vs TNDM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while TNDM trades at $22.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas TNDM's P/E ratio is -20.52. In terms of profitability, BRKR's ROE is -0.03%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, BRKR is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check TNDM's competition here
CONMED Corporation (NYSE: CNMD)
BRKR vs CNMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CNMD trades at $51.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CNMD's P/E ratio is 11.29. In terms of profitability, BRKR's ROE is -0.03%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CNMD's competition here
Enovis Corporation (NYSE: ENOV)
BRKR vs ENOV Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ENOV trades at $26.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ENOV's P/E ratio is 7.50. In terms of profitability, BRKR's ROE is -0.03%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, BRKR is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ENOV's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
BRKR vs ATEC Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ATEC trades at $9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ATEC's P/E ratio is -154.83. In terms of profitability, BRKR's ROE is -0.03%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, BRKR is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ATEC's competition here
Artivion, Inc. (NYSE: AORT)
BRKR vs AORT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while AORT trades at $27.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas AORT's P/E ratio is 46.60. In terms of profitability, BRKR's ROE is -0.03%, compared to AORT's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
BRKR vs HSKA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas HSKA's P/E ratio is -62.49. In terms of profitability, BRKR's ROE is -0.03%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, BRKR is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
BRKR vs IART Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while IART trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas IART's P/E ratio is 7.03. In terms of profitability, BRKR's ROE is -0.03%, compared to IART's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check IART's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
BRKR vs PRCT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while PRCT trades at $20.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas PRCT's P/E ratio is -10.69. In terms of profitability, BRKR's ROE is -0.03%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, BRKR is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
BRKR vs AVNS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas AVNS's P/E ratio is 27.77. In terms of profitability, BRKR's ROE is -0.03%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, BRKR is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
BRKR vs LMRI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while LMRI trades at $11.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas LMRI's P/E ratio is -22.73. In terms of profitability, BRKR's ROE is -0.03%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, BRKR is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
BRKR vs SILK Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SILK's P/E ratio is -18.96. In terms of profitability, BRKR's ROE is -0.03%, compared to SILK's ROE of -0.35%. Regarding short-term risk, BRKR is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
BRKR vs IRMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while IRMD trades at $86.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas IRMD's P/E ratio is 43.56. In terms of profitability, BRKR's ROE is -0.03%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, BRKR is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
BRKR vs FNA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas FNA's P/E ratio is -19.83. In terms of profitability, BRKR's ROE is -0.03%, compared to FNA's ROE of -0.35%. Regarding short-term risk, BRKR is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
BRKR vs BVS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BVS has a market cap of 970.8M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BVS trades at $14.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BVS's P/E ratio is 18.86. In terms of profitability, BRKR's ROE is -0.03%, compared to BVS's ROE of +0.28%. Regarding short-term risk, BRKR is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
BRKR vs CBLL Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CBLL has a market cap of 922.4M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CBLL trades at $24.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CBLL's P/E ratio is -14.91. In terms of profitability, BRKR's ROE is -0.03%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, BRKR is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CBLL's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
BRKR vs AVR Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, AVR has a market cap of 899.4M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while AVR trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas AVR's P/E ratio is -4.15. In terms of profitability, BRKR's ROE is -0.03%, compared to AVR's ROE of -0.78%. Regarding short-term risk, BRKR is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check AVR's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
BRKR vs BBNX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BBNX has a market cap of 876.4M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BBNX trades at $19.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BBNX's P/E ratio is -12.90. In terms of profitability, BRKR's ROE is -0.03%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, BRKR is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BBNX's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
BRKR vs SIBN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SIBN has a market cap of 863.9M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SIBN trades at $19.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SIBN's P/E ratio is -57.29. In terms of profitability, BRKR's ROE is -0.03%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, BRKR is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
BRKR vs INMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, INMD has a market cap of 857.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while INMD trades at $14.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas INMD's P/E ratio is 10.36. In terms of profitability, BRKR's ROE is -0.03%, compared to INMD's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
BRKR vs CSII Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CSII's P/E ratio is -20.83. In terms of profitability, BRKR's ROE is -0.03%, compared to CSII's ROE of -0.14%. Regarding short-term risk, BRKR is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CSII's competition here
Varex Imaging Corporation (NASDAQ: VREX)
BRKR vs VREX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, VREX has a market cap of 778.4M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while VREX trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas VREX's P/E ratio is 19.46. In terms of profitability, BRKR's ROE is -0.03%, compared to VREX's ROE of +0.05%. Regarding short-term risk, BRKR is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
BRKR vs AHCO Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, AHCO has a market cap of 733.3M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while AHCO trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas AHCO's P/E ratio is 11.00. In terms of profitability, BRKR's ROE is -0.03%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, BRKR is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
BRKR vs SSII Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SSII has a market cap of 722.5M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SSII trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SSII's P/E ratio is -70.41. In terms of profitability, BRKR's ROE is -0.03%, compared to SSII's ROE of -0.27%. Regarding short-term risk, BRKR is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check SSII's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
BRKR vs KIDS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, KIDS has a market cap of 673.7M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while KIDS trades at $26.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas KIDS's P/E ratio is -22.23. In terms of profitability, BRKR's ROE is -0.03%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, BRKR is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check KIDS's competition here
Surmodics, Inc. (NASDAQ: SRDX)
BRKR vs SRDX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SRDX's P/E ratio is -34.66. In terms of profitability, BRKR's ROE is -0.03%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, BRKR is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
BRKR vs CTKB Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CTKB has a market cap of 601.8M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CTKB trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CTKB's P/E ratio is -24.69. In terms of profitability, BRKR's ROE is -0.03%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, BRKR is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CTKB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
BRKR vs BWAY Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BWAY has a market cap of 587.2M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BWAY trades at $14.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BWAY's P/E ratio is 38.03. In terms of profitability, BRKR's ROE is -0.03%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, BRKR is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BWAY's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
BRKR vs APEN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas APEN's P/E ratio is -9.43. In terms of profitability, BRKR's ROE is -0.03%, compared to APEN's ROE of -0.85%. Regarding short-term risk, BRKR is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
BRKR vs DCTH Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, DCTH has a market cap of 578.2M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while DCTH trades at $16.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas DCTH's P/E ratio is 1675.00. In terms of profitability, BRKR's ROE is -0.03%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, BRKR is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check DCTH's competition here
Cerus Corporation (NASDAQ: CERS)
BRKR vs CERS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CERS has a market cap of 562.3M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CERS trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CERS's P/E ratio is -55.69. In terms of profitability, BRKR's ROE is -0.03%, compared to CERS's ROE of -0.10%. Regarding short-term risk, BRKR is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CERS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
BRKR vs ZIMV Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, BRKR's ROE is -0.03%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
BRKR vs TCMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, TCMD has a market cap of 528.5M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while TCMD trades at $23.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas TCMD's P/E ratio is 26.63. In terms of profitability, BRKR's ROE is -0.03%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, BRKR is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
BRKR vs NPCE Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, NPCE has a market cap of 478M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while NPCE trades at $14.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas NPCE's P/E ratio is -24.60. In terms of profitability, BRKR's ROE is -0.03%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, BRKR is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
BRKR vs CLPT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CLPT has a market cap of 455.5M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CLPT trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CLPT's P/E ratio is -12.87. In terms of profitability, BRKR's ROE is -0.03%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, BRKR is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CLPT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
BRKR vs CARL Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CARL has a market cap of 448.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CARL trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CARL's P/E ratio is -11.54. In terms of profitability, BRKR's ROE is -0.03%, compared to CARL's ROE of -0.38%. Regarding short-term risk, BRKR is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CARL's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
BRKR vs SGHT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SGHT has a market cap of 443.4M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SGHT trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SGHT's P/E ratio is -14.55. In terms of profitability, BRKR's ROE is -0.03%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, BRKR is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SGHT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
BRKR vs OFIX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, OFIX has a market cap of 404.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while OFIX trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas OFIX's P/E ratio is -13.08. In terms of profitability, BRKR's ROE is -0.03%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, BRKR is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check OFIX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
BRKR vs PACB Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, PACB has a market cap of 382M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while PACB trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas PACB's P/E ratio is -3.00. In terms of profitability, BRKR's ROE is -0.03%, compared to PACB's ROE of -49.62%. Regarding short-term risk, BRKR is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PACB's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
BRKR vs SENS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SENS has a market cap of 368.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SENS trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SENS's P/E ratio is -4.41. In terms of profitability, BRKR's ROE is -0.03%, compared to SENS's ROE of -1.66%. Regarding short-term risk, BRKR is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SENS's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
BRKR vs CATX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CATX has a market cap of 367.2M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CATX trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CATX's P/E ratio is -2.42. In terms of profitability, BRKR's ROE is -0.03%, compared to CATX's ROE of -0.42%. Regarding short-term risk, BRKR is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CATX's competition here
Picard Medical, Inc. (AMEX: PMI)
BRKR vs PMI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, PMI has a market cap of 333.8M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while PMI trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas PMI's P/E ratio is -2.71. In terms of profitability, BRKR's ROE is -0.03%, compared to PMI's ROE of -9.31%. Regarding short-term risk, BRKR is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PMI's competition here
Electromed, Inc. (AMEX: ELMD)
BRKR vs ELMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ELMD has a market cap of 333.1M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ELMD trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ELMD's P/E ratio is 34.39. In terms of profitability, BRKR's ROE is -0.03%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, BRKR is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
BRKR vs TLSI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, TLSI has a market cap of 322M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while TLSI trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas TLSI's P/E ratio is -3.11. In terms of profitability, BRKR's ROE is -0.03%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, BRKR is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check TLSI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
BRKR vs SMLR Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas SMLR's P/E ratio is 3.92. In terms of profitability, BRKR's ROE is -0.03%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SMLR's competition here
CapsoVision, Inc. (NASDAQ: CV)
BRKR vs CV Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, CV has a market cap of 295.3M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while CV trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas CV's P/E ratio is -2.36. In terms of profitability, BRKR's ROE is -0.03%, compared to CV's ROE of -1.78%. Regarding short-term risk, BRKR is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CV's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
BRKR vs TMCI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, TMCI has a market cap of 289.3M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while TMCI trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas TMCI's P/E ratio is -4.74. In terms of profitability, BRKR's ROE is -0.03%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, BRKR is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check TMCI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
BRKR vs ANIK Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ANIK has a market cap of 285.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ANIK trades at $21.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ANIK's P/E ratio is 43.55. In terms of profitability, BRKR's ROE is -0.03%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, BRKR is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ANIK's competition here
RxSight, Inc. (NASDAQ: RXST)
BRKR vs RXST Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, RXST has a market cap of 252.1M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while RXST trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas RXST's P/E ratio is -6.55. In terms of profitability, BRKR's ROE is -0.03%, compared to RXST's ROE of -0.17%. Regarding short-term risk, BRKR is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check RXST's competition here
Avita Medical Inc. (NASDAQ: RCEL)
BRKR vs RCEL Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, RCEL has a market cap of 250.7M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while RCEL trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas RCEL's P/E ratio is -6.43. In terms of profitability, BRKR's ROE is -0.03%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, BRKR is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check RCEL's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
BRKR vs MGRM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas MGRM's P/E ratio is -12.00. In terms of profitability, BRKR's ROE is -0.03%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, BRKR is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check MGRM's competition here
Profound Medical Corp. (NASDAQ: PROF)
BRKR vs PROF Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, PROF has a market cap of 241.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while PROF trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas PROF's P/E ratio is -5.36. In terms of profitability, BRKR's ROE is -0.03%, compared to PROF's ROE of -0.56%. Regarding short-term risk, BRKR is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PROF's competition here
Nevro Corp. (NYSE: NVRO)
BRKR vs NVRO Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas NVRO's P/E ratio is -1.91. In terms of profitability, BRKR's ROE is -0.03%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, BRKR is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
BRKR vs STIM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, STIM has a market cap of 215M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while STIM trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas STIM's P/E ratio is -5.72. In terms of profitability, BRKR's ROE is -0.03%, compared to STIM's ROE of -1.51%. Regarding short-term risk, BRKR is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
BRKR vs BSGM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas BSGM's P/E ratio is -5.81. In terms of profitability, BRKR's ROE is -0.03%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, BRKR is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
BRKR vs LUCD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, LUCD has a market cap of 183.2M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while LUCD trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas LUCD's P/E ratio is -2.60. In terms of profitability, BRKR's ROE is -0.03%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, BRKR is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
BRKR vs MDGS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas MDGS's P/E ratio is -0.27. In terms of profitability, BRKR's ROE is -0.03%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, BRKR is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
BRKR vs QIPT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas QIPT's P/E ratio is -15.87. In terms of profitability, BRKR's ROE is -0.03%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, BRKR is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
BRKR vs FOCL Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, FOCL has a market cap of 158.9M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while FOCL trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas FOCL's P/E ratio is -4.10. In terms of profitability, BRKR's ROE is -0.03%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, BRKR is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check FOCL's competition here
Inogen, Inc. (NASDAQ: INGN)
BRKR vs INGN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, INGN has a market cap of 151.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while INGN trades at $5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas INGN's P/E ratio is -6.15. In terms of profitability, BRKR's ROE is -0.03%, compared to INGN's ROE of -0.13%. Regarding short-term risk, BRKR is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
BRKR vs QTRX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, QTRX has a market cap of 147M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while QTRX trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas QTRX's P/E ratio is -1.23. In terms of profitability, BRKR's ROE is -0.03%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, BRKR is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check QTRX's competition here
Solana Company (NASDAQ: HSDT)
BRKR vs HSDT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, HSDT has a market cap of 108.6M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while HSDT trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas HSDT's P/E ratio is -0.02. In terms of profitability, BRKR's ROE is -0.03%, compared to HSDT's ROE of -1.23%. Regarding short-term risk, BRKR is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check HSDT's competition here
iCAD, Inc. (NASDAQ: ICAD)
BRKR vs ICAD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas ICAD's P/E ratio is -20.37. In terms of profitability, BRKR's ROE is -0.03%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, BRKR is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
BRKR vs OWLT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, OWLT has a market cap of 101.4M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while OWLT trades at $5.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas OWLT's P/E ratio is -40.04. In terms of profitability, BRKR's ROE is -0.03%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, BRKR is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check OWLT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
BRKR vs HJLI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9.1B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, BRKR is priced at $59.92 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 30.11, whereas HJLI's P/E ratio is N/A. In terms of profitability, BRKR's ROE is -0.03%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, BRKR is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check HJLI's competition here